Impact of a Collaborative Program of Physical Activity of Newly-diagnosed Cancer Patients

During the last twenty years, the cancer overall incidence has been increasing in europe and developed countries, while diagnostic and therapeutic progress have contributes to a reduction in mortality. Currently, almost 4 million people are treated or followed for cancer in France. The physical, psychological and social after-effects are significant.

Adaptated physical activity plays an important role in the rehabilitation process. Overall, meta-analyses carried-out with most frequent cancers demonstrate that physical activity practiced would allow an improvement in quality of life, tolerance to anticancer treatments and survival.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Cancer Neoplasms

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

CHRU de Nancy, Nancy, France

About this study

This is a multicenter, two-arm parallel-group randomizes (in a 1:1 ratio), open-label, controlled intervention clinical trial of the comparison of long term adherence to physical activity between an adaptative, customized and collaborative exercise program and standard exercise prescription in patients with newly diagnosed cancer.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

newly-diagnosed cancer patient
able to start a program of physical activity within the first year follow diagnosis
performance status between 0 to 2

Exclusion criteria

uncontrolled cardiovascular disease
peripheral neuropathy grade 3-4 with risk of falling
bone metastasis with risk of bone fracture
platelets <100X109/L
hemoglobin <8g/dL
patient under legal protection

Treatment and study plan

Adaptative Physical Activity

Other

12 weeks of a collaborative program of customized, adaptative and supervised physical activity by sports instructor

Primary outcomes

Number of physical activity session

Time frame: 2 years

improvement of long-term adhesion to physical activity

Study contacts

Contact information is provided by the study sponsor or research team.

Laura BOGDANOVITCH

CONTACT

[email protected]

0561778437 ext. 33

Sponsors and collaborators

Lead sponsor

University Hospital, Toulouse

Other

Registry information

Official study title

Impact of a Collaborative Program of Customized, Adaptive and Supervised Physical Activity on Adherence, Fitness, Quality of Life and Resilience of Newly-diagnosed Cancer Patients

Acronym: PROGRESS

Important dates

Study start: 2024
Primary completion: 2028
Study completion: 2028
First posted: Feb 10, 2023
Registry last updated: Apr 10, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Recruiting